ICU Medical Statistics
Total Valuation
ICU Medical has a market cap or net worth of $3.07 billion. The enterprise value is $4.10 billion.
| Market Cap | 3.07B |
| Enterprise Value | 4.10B |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU Medical has 24.69 million shares outstanding. The number of shares has increased by 2.12% in one year.
| Current Share Class | 24.99M |
| Shares Outstanding | 24.69M |
| Shares Change (YoY) | +2.12% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 104.17% |
| Float | 24.04M |
Valuation Ratios
The trailing PE ratio is 4,188.91 and the forward PE ratio is 71.99. ICU Medical's PEG ratio is 6.54.
| PE Ratio | 4,188.91 |
| Forward PE | 71.99 |
| PS Ratio | 1.37 |
| Forward PS | 1.40 |
| PB Ratio | 1.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 33.40 |
| P/OCF Ratio | 17.05 |
| PEG Ratio | 6.54 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.23, with an EV/FCF ratio of 44.69.
| EV / Earnings | 5,604.98 |
| EV / Sales | 1.84 |
| EV / EBITDA | 13.23 |
| EV / EBIT | 37.53 |
| EV / FCF | 44.69 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.63.
| Current Ratio | 2.39 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 4.10 |
| Debt / FCF | 14.69 |
| Interest Coverage | 1.17 |
Financial Efficiency
Return on equity (ROE) is 0.04% and return on invested capital (ROIC) is 0.79%.
| Return on Equity (ROE) | 0.04% |
| Return on Assets (ROA) | 1.66% |
| Return on Invested Capital (ROIC) | 0.79% |
| Return on Capital Employed (ROCE) | 3.08% |
| Weighted Average Cost of Capital (WACC) | 6.51% |
| Revenue Per Employee | $171,636 |
| Profits Per Employee | $56 |
| Employee Count | 13,000 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.35 |
Taxes
In the past 12 months, ICU Medical has paid $2.44 million in taxes.
| Income Tax | 2.44M |
| Effective Tax Rate | 76.90% |
Stock Price Statistics
The stock price has decreased by -16.49% in the last 52 weeks. The beta is 0.80, so ICU Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -16.49% |
| 50-Day Moving Average | 143.55 |
| 200-Day Moving Average | 134.50 |
| Relative Strength Index (RSI) | 35.74 |
| Average Volume (20 Days) | 300,623 |
Short Selling Information
The latest short interest is 1.19 million, so 4.83% of the outstanding shares have been sold short.
| Short Interest | 1.19M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 4.83% |
| Short % of Float | 4.96% |
| Short Ratio (days to cover) | 4.10 |
Income Statement
In the last 12 months, ICU Medical had revenue of $2.23 billion and earned $732,000 in profits. Earnings per share was $0.03.
| Revenue | 2.23B |
| Gross Profit | 822.04M |
| Operating Income | 109.33M |
| Pretax Income | 3.17M |
| Net Income | 732,000 |
| EBITDA | 310.08M |
| EBIT | 109.33M |
| Earnings Per Share (EPS) | $0.03 |
Balance Sheet
The company has $311.71 million in cash and $1.35 billion in debt, with a net cash position of -$1.04 billion or -$41.98 per share.
| Cash & Cash Equivalents | 311.71M |
| Total Debt | 1.35B |
| Net Cash | -1.04B |
| Net Cash Per Share | -$41.98 |
| Equity (Book Value) | 2.12B |
| Book Value Per Share | 86.03 |
| Working Capital | 691.69M |
Cash Flow
In the last 12 months, operating cash flow was $179.85 million and capital expenditures -$88.04 million, giving a free cash flow of $91.80 million.
| Operating Cash Flow | 179.85M |
| Capital Expenditures | -88.04M |
| Depreciation & Amortization | 200.74M |
| Net Borrowing | -304.49M |
| Free Cash Flow | 91.80M |
| FCF Per Share | $3.72 |
Margins
Gross margin is 36.84%, with operating and profit margins of 4.90% and 0.03%.
| Gross Margin | 36.84% |
| Operating Margin | 4.90% |
| Pretax Margin | 0.14% |
| Profit Margin | 0.03% |
| EBITDA Margin | 13.90% |
| EBIT Margin | 4.90% |
| FCF Margin | 4.11% |
Dividends & Yields
ICU Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.12% |
| Shareholder Yield | -2.12% |
| Earnings Yield | 0.02% |
| FCF Yield | 2.99% |
Analyst Forecast
The average price target for ICU Medical is $182.25, which is 46.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $182.25 |
| Price Target Difference | 46.75% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 4.67% |
| EPS Growth Forecast (5Y) | 232.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 18, 2002. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
ICU Medical has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.14 |
| Piotroski F-Score | 6 |